There is a continuing search for the ideal substitute for the cruciate
ligaments. Autogenous tissues are widely used as replacement but allo
grafts are an at tractive alternative: no donor side morbidity, decrea
sed operation time, smaller incisions especially with new endoscopic t
echniques, unlimited supply especially for multiple ligament recontruc
tions and a long shelf life are potential advantages of allografts. Th
ey may be useful in circumstances where no suitable autologous substit
ute is available. The use of an allograft requires appropriate donor s
election and screening, careful surgical tissue procurement and safe a
nd effective processing techniques. However, subclinical immun respons
es and the possibility of transmission of viral infections (i.e. HIV)
must be considered. The role of graft processing and secondary sterili
zation of allografts are not clear. Although results in the literature
and in our series are encouraging, the lack of patient safety is a ma
jor drawback against allograft tissue at the present time. The authors
reserve allografts presently for use in very special indications.